Cancer Investigation · 2009 · 29 citations · 16 references
MedicineMolecular BiologyOncologyDna RepairEpigeneticsMolecular OncologyCancer EpigeneticsDna MethylationEpigenetic Alterations In CancerEpigenetic Regulation In CancerGlioblastomaMalignant NeoplasmsAberrant Dna MethylationDna MethyltransferasesGlioblastoma PrognosisMethylation-specific AmplificationP53 InactivationP53 MutationPromoter HypermethylationPromoter Methylation
O(6)-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes alkyl groups from the O(6) position of guanine. MGMT is transcriptionally silenced by promoter hypermethylation in several human neoplasia. We used methylation-specific PCR (MSP) to analyze the MGMT promoter methylation status of 50 glioblastoma tumors. Hypermethylation was detected in 24 of 50 (48%) samples. We also analyzed mutant p53 expression by immunohistochemical analysis of glioblastoma tissue samples. A significant association was found between MGMT methylation and p53 mutation status (p< .05). These results suggested that epigenetic inactivation of MGMT plays an important role in the survival of glioblastoma patients and this inactivated gene involved in p53 mutation.
16
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text